No products in the cart.
Liraglutide Injection
$2.00
Liraglutide 18mg in a 3ml prefilled pen, branded Tonboli, produced by Tonghua Dongbao Pharmaceutical Co., Ltd. Approved under NMPA S20230066, ideal for GLP-1 receptor agonist research, metabolic studies, and diabetes modelling.
Description
Description
Product name: Liraglutide injection (Tongboli/Dongbao)
Packaging specifications: Pre-filled 3ml:18mg Product dosage form: injection Packaging unit: stick/box
Approval number: National Medicine Standard S20230066 Drug code: 86903546001121
Manufacturer: Tonghua Dongbao Pharmaceutical Co., Ltd.
Liraglutide Injection (Tonboli) is a domestically manufactured GLP?1 receptor agonist and the second Chinese-made solution approved for type 2 diabetes treatment. Developed as a biosimilar to Novo Nordisk’s Victoza®, it received regulatory approval under NMPA S20230066 in December 2023.
Active Ingredient: Liraglutide, a 97% human GLP-1 analog peptide
Formulation: 18mg of liraglutide in 3ml of isotonic, clear solution with stabilizers and phenol
Delivery: Single-dose, prefilled auto-injector pen
Source: Approved by NMPA, produced by Tonghua Dongbao
This innovative biodrug is a key addition to China’s growing family of GLP?1RAs, enabling research into glucose regulation, weight control, cardiovascular effects, and peptide-based therapy mechanisms.
Product Specifications
| Feature | Details |
|---|---|
| Product Name | Liraglutide Prefilled Injection Pen (Tonboli) |
| Strength | 18mg in 3ml (6mg/ml) |
| Form | Prefilled pen injection |
| Manufacturer | Tonghua Dongbao Pharmaceutical Co., Ltd. |
| Approval Number (NMPA) | S20230066 |
| Product Code | 86903546001121 |
| Area of Registration | Class 3.3 therapeutic biologic |
| Storage Conditions | Refrigerate at 2–8°C; protect from light; do not freeze |
| Shelf Life | 30 months (first-use pen: 30 days at 30°C) |
| Appearance | Clear, colorless, isotonic solution |
| Barcode | (Insert if available) |
| Intended Use | For laboratory research / analytical study only |
Mechanism & Clinical Data
GLP-1 receptor activation promotes insulin secretion, suppresses glucagon, and slows gastric emptying.
Approved for glycaemic control in adults with T2DM; Tonboli represents China’s second domestic GLP-1RA.
Tonghua Dongbao continues advancing its GLP-1 pipeline, including semaglutide and GLP-1/GIP dual agonists.
International rollout is supported through cooperation with Sinovac in emerging markets.
Why Choose Tonboli Liraglutide?
Research-grade GLP-1RA with reliable production
NMPA-approved and China-manufactured, ensuring traceability
Prefilled pen offers precise dosing for studies
Supports robust metabolic, peptide pharmacokinetics, and cardiovascular research pipelines
Semaglutide Injection (Ozempic®) – GLP-1 RA
Dual GLP?1/GIP Agonist Peptide Pharmaceuticals
Sitagliptin – DPP 4 Inhibitor Tablets
Empagliflozin – SGLT 2 Inhibitor Tablets
Summary
Tonboli Liraglutide 18mg/3ml prefilled pen is a domestically approved GLP-1RA suitable for research into metabolic and cardiovascular pathways. With high regulatory confidence, peptide-level precision, and prefilled format, it’s well-suited for academic and lab settings.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 26 × 25 × 28 cm |
1 review for Liraglutide Injection
Related products
Brolucizumab Injection (Beovu) 27.6mg/0.23ml – Factory low price wholesale
Beovu (Brolucizumab Injection) is supplied in a 0.23ml single-dose vial containing 27.6mg of active ingredient. Manufactured by Alcon-Couvreur N.V. and NMPA-approved under SJ20250019. Intended for non-clinical research use only.?For wholesale prices, other specifications and uses, please consult our staff? $2.00Vildagliptin Tablets (Mingxin) 50mg – For Laboratory Research Use Only
Vildagliptin Tablets (Mingxin) deliver 50mg per tablet, packaged as 14 tablets × 2 blisters. Manufactured by Jinan Mingxin Pharmaceutical Co., Ltd. Approved under H20234624. For laboratory research use only. Supports wholesale and retail orders.?For wholesale prices, other specifications and uses, please consult our staff?
$2.00Linagliptin Tablets
High-purity Linagliptin 5mg tablets, 7count bottle packaging by Yangtze River Pharmaceutical Group – Shanghai Henley Pharma. Ideal for DPP4 inhibitor research into Type2 diabetes mechanisms, incretin pathways, and metabolic regulation.
$2.00
For laboratory research only – Not for human consumption or therapeutic use.Proline Dapagliflozin Tablets
Huiyoujing – Proline + Dapagliflozin Tablets 50mg/5mg, 14 tablets/box. Innovative dual SGLT-2 class?1 drug, Reminder: strictly for laboratory research use only. $2.00
david –
thank you friend